CN114144183A - 治疗与疼痛相关的睡眠障碍的方法 - Google Patents

治疗与疼痛相关的睡眠障碍的方法 Download PDF

Info

Publication number
CN114144183A
CN114144183A CN202080052544.6A CN202080052544A CN114144183A CN 114144183 A CN114144183 A CN 114144183A CN 202080052544 A CN202080052544 A CN 202080052544A CN 114144183 A CN114144183 A CN 114144183A
Authority
CN
China
Prior art keywords
pain
sleep
fmsd
compound
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202080052544.6A
Other languages
English (en)
Chinese (zh)
Inventor
保罗·布拉亨卡
杰拉德·马雷克
凯瑟琳·特蕾西
玛丽·贝思·布劳维特
迈克尔·史密斯
马克·沃尔泽
玛希·英格雷诗
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astras Pharmaceutical Global Development Co ltd
Original Assignee
Astras Pharmaceutical Global Development Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astras Pharmaceutical Global Development Co ltd filed Critical Astras Pharmaceutical Global Development Co ltd
Publication of CN114144183A publication Critical patent/CN114144183A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN202080052544.6A 2019-07-23 2020-07-22 治疗与疼痛相关的睡眠障碍的方法 Pending CN114144183A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962877573P 2019-07-23 2019-07-23
US62/877,573 2019-07-23
PCT/US2020/043047 WO2021016338A1 (en) 2019-07-23 2020-07-22 Methods of treating sleep disorders associated with pain

Publications (1)

Publication Number Publication Date
CN114144183A true CN114144183A (zh) 2022-03-04

Family

ID=72047043

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080052544.6A Pending CN114144183A (zh) 2019-07-23 2020-07-22 治疗与疼痛相关的睡眠障碍的方法

Country Status (10)

Country Link
US (1) US20220370468A1 (https=)
EP (1) EP4003357A1 (https=)
JP (1) JP2022541634A (https=)
KR (1) KR20220038344A (https=)
CN (1) CN114144183A (https=)
AU (1) AU2020318996A1 (https=)
BR (1) BR112022001056A2 (https=)
CA (1) CA3147752A1 (https=)
MX (1) MX2022000892A (https=)
WO (1) WO2021016338A1 (https=)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1845743A (zh) * 2003-09-03 2006-10-11 诺瓦提斯公司 奥卡西平在治疗糖尿病性神经性疼痛和改善睡眠中的用途
CN105263926A (zh) * 2013-06-06 2016-01-20 安斯泰来制药株式会社 苯并噻吩化合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX350745B (es) * 2009-11-06 2017-09-14 Sk Biopharmaceuticals Co Ltd * El uso de un compuesto de carbamoilo para el tratamiento del sindrome de fibromialgia.

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1845743A (zh) * 2003-09-03 2006-10-11 诺瓦提斯公司 奥卡西平在治疗糖尿病性神经性疼痛和改善睡眠中的用途
CN105263926A (zh) * 2013-06-06 2016-01-20 安斯泰来制药株式会社 苯并噻吩化合物

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SUELY ROIZENBLATT，等: "Sleep Disorders and Fibromyalgia", 《CURR PAIN HEADACHE REP》, vol. 15, pages 347 - 354 *

Also Published As

Publication number Publication date
KR20220038344A (ko) 2022-03-28
BR112022001056A2 (pt) 2022-05-24
JP2022541634A (ja) 2022-09-26
MX2022000892A (es) 2022-03-11
AU2020318996A1 (en) 2022-02-03
CA3147752A1 (en) 2021-01-28
EP4003357A1 (en) 2022-06-01
WO2021016338A1 (en) 2021-01-28
US20220370468A1 (en) 2022-11-24

Similar Documents

Publication Publication Date Title
Kroenke et al. Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews
AU2019384963B2 (en) Methods of treating Rett syndrome using fenfluramine
US20250177378A1 (en) Treatment of depression
WO2016062285A1 (zh) 神经系统疾病用药在制备抗癌医药组合物中的应用
Hosseini et al. Acute pain management for older adults
Hauer et al. Pediatric pain and symptom management guidelines
WO2013042054A1 (en) Buprenorphine for the treatment of acute suicidality
Grima et al. Insomnia management
Gourlay et al. A controlled study of a serotonin reuptake blocker, zimelidine, in the treatment of chronic pain
TW202228666A (zh) 使用ghb之治療方法
US20230134935A1 (en) Medical use of daridorexant
CN114144183A (zh) 治疗与疼痛相关的睡眠障碍的方法
Moline Pain management in the ambulatory surgical population
Zheng et al. Tolerability of biphasic-release hydrocodone bitartrate/acetaminophen tablets (MNK-155): A phase III, multicenter, open-label study in patients with osteoarthritis or chronic low back pain
US20220401391A1 (en) Methods and compositions for treating pain
Vaughan et al. Pain Assessment and Management
Park et al. Current pharmacological management of chronic pain
US20250367212A1 (en) Pharmacotherapy for obsessive-compulsive disorder targeting dopamine d1 signal in striatal striosomes
Parker et al. Epidemiology of Opioid Use and Smoking, Alcohol, and Polysubstance Use Among Persons Using Opioids
Singhal et al. Who is pushing patients to death trap by improper use of codeine? Time now to reorient physicians or ban the use of codeine!
Kawahito et al. Successful treatment of mixed (mainly cancer) pain by tramadol preparations
Hemraj et al. Persistent Pain in the Older Adult: Practical Considerations for
Engeriser et al. Buprenorphine initiation from fentanyl using low-dose intramuscular ketamine: a pilot study
Gowan et al. Pain management in older people—in aged care facilities and in the community.
Days Union| Digital Work s

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20220304